Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 406 participants.

Also called NCT05359224

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 406 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05359224
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05359224. Randomized; no masking; primary purpose treatment. Start 2022-06-13 (actual); primary completion 2025-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
Condition
Intracranial Aneurysm
Intervention (Drug)
Prasugrel group
Intervention (Drug)
Clopidogrel group
Lead sponsor
Yonsei University (class: other)
Collaborator
Severance Hospital (class: other)
Collaborator
Gangnam Severance Hospital (class: other)
Collaborator
Bucheon St. Mary's Hospital (class: other)
Collaborator
International St. Mary's Hospital (class: not stated)
Collaborator
Ewha Womans University Seoul Hospital (class: other)

Record details

Record id
cardio:ct-nct05359224
Content hash
461d5e12e23297df88f0b57db23c202e0b3551f3e67edcd7e08f6e6cce3a50e2